Announcements

May 6th, 2009
Industry Lecture Series: "Academia-Industry Partnerships Seeding the Next Generation of Novel Therapies"

March 30th, 2009
DiscoveryBioMed, Inc. Engaged in Multiple Drug Discovery Projects on Behalf of Mount Sinai School of Medicine and its Office of Technology and Business Development

March 18th, 2009
Industry Lecture Series: "Advancing Early Stage Technology"

January 8, 2009
Vivaldi Biosciences Enters into Agreements for $23 Million in Series A

Ocober 22, 2008
Antigenics Submits Oncophage(R) Application for European Approval (Reuters)

September 12, 2008
Forbes lists Mount Sinai School of Medicine among the top 15 licensing revenue generating schools

September 18, 2006
Clavis Pharma and Mount Sinai School of Medicine have entered into collaboration agreement for the development of new cancer drugs